EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Dysfunction of Mesenchymal Stem Cells Isolated from Metabolic Syndrome and Type 2 Diabetic Patients as Result of Oxidative Stress and Autophagy may Limit Their Potential Therapeutic Use

Katarzyna Kornicka, Jenny Houston, Krzysztof Marycz

Stem Cell Reviews and Reports · 2018-06 · 14 (3) · 337-345

DOI: 10.1007/s12015-018-9809-x ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Stem Cell Reviews and Reports, online erschienen am 03.04.2018. Verfasst von Katarzyna Kornicka und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Biology, The Faculty of Biology and Animal Science, Wroclaw University of Environmental and Life Sciences, Norwida 25, 50-…. Die Arbeit wurde bisher 161-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Narodowe Centrum Nauki, Krajowy Naukowy Osrodek Wiodacy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mesenchymal stem cells (MSC) have become a promising tool for therapeutic intervention. Their unique features, including self-renewal, multipotency and immunomodulatory properties draw the worldwide attention of researchers and physicians with respect to their application in disease treatment. However, the environment (so-called niche) from which MSCs are isolated may determine their usefulness. Many studies indicated the involvement of MSCs in ageing and disease. In this review, we have focused on how type 2 diabetes (T2D) and metabolic syndrome (MS) affect MSC properties, and thus limit their therapeutic potential. Herein, we mainly focus on apoptosis, autophagy and mitochondria deterioration processes that indirectly affect MSC fate. Based on the data presented, special attention should be paid when considering autologous MSC therapy in T2D or MS treatments, as their therapeutic potential may be restricted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgingAnimalsAutophagyDiabetes Mellitus, Type 2HumansMesenchymal Stem CellsMetabolic SyndromeOxidative StressRegenerative MedicineSignal Transduction

Stichwörter der Autor:innen

AgingAutophagyDiabetesMesenchymal stem cellsMetabolic syndromeOxidative stressRegenerative medicineSenescence

Autor:innen und Institutionen

  • Department of Experimental Biology, The Faculty of Biology and Animal Science, Wroclaw University of Environmental and Life Sciences, Norwida 25, 50-375, Wrocław, Poland. katarzyna.kornicka@upwr.edu.pl.
  • PferdePraxis Dr. Med. Vet. Daniel Weiss, Postmatte 14, CH-8807, Freienbach, Switzerland.
  • Department of Experimental Biology, The Faculty of Biology and Animal Science, Wroclaw University of Environmental and Life Sciences, Norwida 25, 50-375, Wrocław, Poland.
  • Wroclaw Research Centre EIT+, 54-066, Wroclaw, Poland.

Förderung

  • Narodowe Centrum Nauki
  • Krajowy Naukowy Osrodek Wiodacy

Zitieren

APA

Kornicka, K., Houston, J., & Marycz, K. (2018). Dysfunction of Mesenchymal Stem Cells Isolated from Metabolic Syndrome and Type 2 Diabetic Patients as Result of Oxidative Stress and Autophagy may Limit Their Potential Therapeutic Use. Stem Cell Reviews and Reports, 14(3), 337-345. https://doi.org/10.1007/s12015-018-9809-x

Vancouver

Kornicka K, Houston J, Marycz K. Dysfunction of Mesenchymal Stem Cells Isolated from Metabolic Syndrome and Type 2 Diabetic Patients as Result of Oxidative Stress and Autophagy may Limit Their Potential Therapeutic Use. Stem Cell Reviews and Reports. 2018;14(3):337-345. doi:10.1007/s12015-018-9809-x

BibTeX
@article{Kornicka2018,
  author = {Kornicka, Katarzyna and Houston, Jenny and Marycz, Krzysztof},
  title = {Dysfunction of Mesenchymal Stem Cells Isolated from Metabolic Syndrome and Type 2 Diabetic Patients as Result of Oxidative Stress and Autophagy may Limit Their Potential Therapeutic Use},
  journal = {Stem Cell Reviews and Reports},
  year = {2018},
  volume = {14},
  number = {3},
  pages = {337--345},
  doi = {10.1007/s12015-018-9809-x}
}
Kostenlos starten →